Your doctor must submit a prior authorization request attesting that you met one of the following criteria: Pathway 1: BMI of 35 or higher at the time GLP-1 therapy was initiated (no additional conditions required) Pathway 2: BMI of 30 or higher, plus a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension (systolic blood pressure above 140 mm Hg), or chronic kidney disease stage 3a or higher Pathway 3: BMI of 27 or higher, plus a diagnosis of pre-diabetes (per American Diabetes Association guidelines), a previous heart attack, a previous stroke, or symptomatic peripheral artery disease The medication must also be prescribed in combination with ongoing lifestyle modification, including structured nutrition and physical activity guidance consistent with the FDA-approved drug label
The acquisition, fuelled by Onto Healths US$20m Series A fundraise in April, supports its plan to build scalable, tech-enabled infrastructure for reproductive medicine
Determining Your Eligibility Consider semaglutide weight loss treatment if you have a BMI of 30 or higher, or a BMI of 27 with weight-related conditions like high blood pressure, diabetes, or high cholesterol
How Lipo-Mino Shots Help With Semaglutide Fatigue For patients experiencing fatigue while taking GLP-1 weight loss injections , Lipo-Mino shots may provide several benefits
Start your intake How GLP-1 Receptor Agonists Support Weight Loss GLP-1 (glucagon-like peptide-1) is a natural hormone your body produces after eating
Preference models were estimated using mixed logistic regression and maximum acceptable risk
)
